Adamas Pharmaceuticals Inc. Common Stock (NASDAQ: ADMS)
According to the Complaint, Adamas Pharmaceuticals, Inc. is a commercial stage pharmaceutical company that specializes in developing drug treatment therapies for chronic neurologic disorders.
The Complaint alleges that throughout the Class Period, Adamas' public statements were false and materially misleading.